|
|
 | | | |
- close
- close
- close
- close
Infinity Pharmaceuticals (INFI) |
QUOTE AND NEWS
Business Wire
May 15
Comment
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that the company will be added to the NASDAQ Biotechnology Index® (NBI). The semi-annual re-ranking of the index will become effective prior to market open on Monday, May 21, 2012. “Our
StreetInsider.com
May 8
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Infinity+Pharmaceuticals%2C+Inc.+%28INFI%29+Misses+Q1+EPS+by+3c/7416154.html for the full story.
Business Wire
May 8
Comment
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today reported its financial results for the first quarter of 2012. The company maintained its strong financial condition while continuing to advance its clinical programs during the quarter toward the
Business Wire
May 1
Comment
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, May 8, 2012, at 4:30 p.m. ET. During the call, management will provide an update on Infinity’s business and discuss the company’s first quarter 2012 financial
Business Wire
Apr 13
Comment
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the BioCentury Future Leaders in the Biotech Industry Conference on Friday, April 20, 2012, at 11:00 a.m. ET in New York City. In addition, Infinity will also be presenting at the
StreetInsider.com
Apr 2
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Infinity+Pharma+%28INFI%29+Presented+Encouraging+Data+for+IPI-926+at+AACR/7312250.html for the full story.
Business Wire
Apr 1
Comment
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today presented new preclinical data for saridegib (IPI-926), its novel oral molecule that inhibits Smoothened, a key component of the Hedgehog pathway. Data presented showed the anti-tumor activity of
Business Wire
Mar 28
Comment
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the Needham 11th Annual Health Care Conference on Wednesday, April 4, 2012, in New York. A live webcast of Infinity's presentation will be accessible on the “investors/media”
Benzinga
Mar 13
Comment
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today highlighted its clinical and financial outlook and announced its full-year and fourth quarter 2011 financial results.
“We made substantial progress advancing our clinical programs in the...
Business Wire
Mar 12
Comment
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has appointed Gwen A. Fyfe, M.D., and Norman C. Selby as independent members of its board of directors. Dr. Fyfe is an oncology biotechnology veteran with more than 20 years of
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
| |||||||
